Socomed Pharma Private Limited - Due diligence report

A 360° intelligence report on Socomedpharma: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2008-04-24 Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Socomedpharma — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Socomedpharma is assessed as Low Risk with a Trust Score of 75/100. Socomedpharma is an active private limited indian non-government company incorporated in 2008, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 21 Nov 2026 from the latest processed filings. Socomed Pharma Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
56/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 0 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (SME).

Charges position: 1 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).

Banking relationships (from registered charges)
LenderChargesAmount
Standard Chartered Bank1 48.0 cr
Compliance Score: 56/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 2 court forum(s).
  • 1 auditor resignation(s) filed - latest: B Y & ASSOCIATES on 2018-09-29.
  • Delayed payments to MSME suppliers disclosed (401 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AASIF AMIRKHAN DANGE 01234567 Director 01/04/2018 6 yrs Approved
BAKHTAWAR MAIRAJ AASIF DANGE 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
2 allotment(s) · 2 transfer(s)
Group entityRelationship% held
Kind Health And Hygiene Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 75
Growth signals & trust indicators
Net margin improved to 38%.
EPFO headcount growing - hiring signal.
Operating for 18+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Compliance score is weak (56/100).
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence67/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment69/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) already registered.
  • Compliance gaps should be priced into terms.
Investor view63/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2023
Share transfer (FY 2023)
72913.00000000 shares to Aasif Amirkhan Dange
30 Nov 2021
Director ceased
BAKHTAWAR MAIRAJ AASIF DANGE
31 Oct 2021
Director ceased
SYED JAHAN SHAUKAT
01 Oct 2021
Director appointed
BAKHTAWAR MAIRAJ AASIF DANGE (Director)
22 Apr 2019
Charge created
Standard Chartered Bank - 2.53 cr
31 Mar 2017
Share transfer (FY 2017)
5328.00000000 shares to Dange
25 Mar 2013
Securities allotted
2850.00 Equity Shares - 7.38 Lakh raised
22 Feb 2012
Director ceased
LATA SHREEDHAR TIWARI
13 Dec 2011
Director appointed
AASIF AMIRKHAN DANGE (Director)
19 Jan 2009
Securities allotted
10000.00 Equity Shares - 1.00 Lakh raised
24 Apr 2008
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of SME from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
Approximately 20 employees on EPFO payroll records.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Olcare Laboratories Private Limited U24299GJ2018PTC100958 Surendranagar, Gujarat, India
Jac Olivol Products Private Limited U21003WB2019PTC234801 Kolkata, West Bengal, India
Glochem Industries Private Limited U24230TG2020PTC146205 Shaikpet, Telangana, India
Vdh Chem Tech Private Limited U24100DL2011PTC215740 Delhi, Delhi, India
Plant Remedies Private Limited U02423BR1998PTC008446 Patna, Bihar, India
Archimedis Laboratories Private Limited U24239TG2004PTC044970 Hyderabad, Telangana, India
Ecof Industries Private Limited U24246TN1995PTC031245 Chennai, Tamil Nadu, India
Pj Margo U24219KA1991PTC011795 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Socomedpharma before audits and certifications: compliance score 56/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Socomedpharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Socomedpharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Socomedpharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Socomedpharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Socomedpharma an active company?

Socomedpharma has MCA status “Active” with a compliance score of 56/100 (Moderate).

Is Socomedpharma financially healthy?

Socomedpharma has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Socomedpharma?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Socomedpharma?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Socomedpharma have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Socomedpharma up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 56/100 (Moderate).

Is it risky to lend to Socomedpharma?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.